[BDSI] BioDelivery Sciences International, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 1.75 Change: 0.05 (2.94%)
Ext. hours: Change: 0 (0%)

chart BDSI

Refresh chart

Strongest Trends Summary For BDSI

BDSI is in the long-term up 110% in 3 years and down -62% below S&P in 9 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: BioDelivery Sciences International, Inc., a specialty pharmaceutical company, develops and commercializes therapeutics in the areas of pain management and oncology supportive care. The company provides its products based on its patented BioErodible MucoAdhesive (BEMA) drug delivery technology, which consists of a small, bi-layered erodible polymer film for application to the buccal mucosa. Its products include ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in patients with cancer; and BEMA Buprenorphine that is in Phase III trial for the treatment of chronic pain in a mixed opioid naïve and opioid experienced population. The company is also involved in the development of BUNAVAIL for the maintenance treatment of opioid dependence; and Clonidine Topical Gel for the treatment of painful diabetic neuropathy. It has a licensing and development agreement with Endo Pharmaceuticals, Inc. to develop and commercialize BEMA Buprenorphine; and license agreement with Arcion Therapeutics.

Fundamental Ratios
Shares Outstanding EPS-0.35 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -5.98% Sales Growth - Q/Q412.53% P/E-6.57
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-70.05% ROE-115.89% ROI-109.33%
Current Ratio2.42 Quick Ratio2.34 Long Term Debt/Equity0.05 Debt Ratio0.59
Gross Margin82.95% Operating Margin-150.93% Net Profit Margin-184.52% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-1.86 M Cash From Investing Activities-140 K Cash From Operating Activities-5 M Gross Profit11.93 M
Net Profit-8.19 M Operating Profit-7.8 M Total Assets82.47 M Total Current Assets71.74 M
Total Current Liabilities29.59 M Total Debt10.26 M Total Liabilities32.62 M Total Revenue13.05 M
Technical Data
High 52 week5.3 Low 52 week1.7 Last close4.57 Last change-0.44%
RSI36.36 Average true range0.19 Beta0.69 Volume448.88 K
Simple moving average 20 days-5.36% Simple moving average 50 days-6.96% Simple moving average 200 days16.74%
Performance Data
Performance Week-7.86% Performance Month-2.35% Performance Quart-1.3% Performance Half26.24%
Performance Year134.36% Performance Year-to-date23.51% Volatility daily1.98% Volatility weekly4.43%
Volatility monthly9.07% Volatility yearly31.42% Relative Volume117.27% Average Volume1.09 M
New High New Low

News

2020-05-26 10:43:17 | Baker Brothers Snap Up These 3 Small-Cap Biotech Stocks

2020-05-11 08:30:10 | BioDelivery Sciences Appoints Jeff Bailey Interim CEO

2020-05-09 17:01:26 | Biodelivery Sciences International Inc BDSI Q1 2020 Earnings Call Transcript

2020-05-08 18:22:29 | Edited Transcript of BDSI earnings conference call or presentation 7-May-20 8:30pm GMT

2020-05-08 10:52:02 | BioDelivery BDSI Beats on Q1 Earnings, Withdraws Guidance

2020-05-07 18:35:10 | BioDelivery Sciences International BDSI Beats Q1 Earnings and Revenue Estimates

2020-05-07 16:01:10 | BioDelivery Sciences Reports Strong Q1 2020 Results

2020-04-30 12:34:04 | BioDelivery Sciences International BDSI Earnings Expected to Grow: Should You Buy?

2020-04-28 08:00:10 | BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020

2020-04-27 12:31:04 | BioDelivery Sciences International BDSI Earnings Expected to Grow: Should You Buy?

2020-03-14 08:51:35 | Does BioDelivery Sciences International NASDAQ:BDSI Have A Healthy Balance Sheet?

2020-03-13 09:29:01 | BioDelivery BDSI Q4 Earnings and Revenues Beat Estimates

2020-03-13 01:15:48 | Edited Transcript of BDSI earnings conference call or presentation 12-Mar-20 8:30pm GMT

2020-03-12 20:55:12 | BioDelivery Sciences International BDSI Tops Q4 Earnings and Revenue Estimates

2020-03-12 16:01:10 | BioDelivery Sciences Reports Strong Fourth Quarter and Full-Year 2019 Results

2020-03-12 14:30:00 | BioDelivery Sciences International, Inc. to Host Earnings Call

2020-03-09 08:00:10 | BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of Directors

2020-03-05 12:30:05 | BioDelivery Sciences International BDSI Earnings Expected to Grow: Should You Buy?

2020-02-27 17:15:10 | BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicine’s 36th Annual Meeting

2020-02-24 14:59:43 | Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus

2020-02-20 08:00:10 | BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

2020-02-06 10:44:03 | Emmaus EMMA to Report Q4 Earnings: What's in the Cards?

2020-01-30 10:15:03 | Alexion ALXN Q4 Earnings Beat Estimates, Revenues Up Y/Y

2020-01-29 10:06:03 | Gilead's Mantle Cell Lymphoma Drug MAA Gets EMA Validation

2020-01-27 17:20:10 | Here's Why You Should Add BioDelivery Stock to Your Portfolio

2020-01-27 10:25:03 | Will Soliris, Ultomiris Drive Alexion's ALXN Q4 Earnings?

2020-01-13 08:30:10 | BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Access for Symproic

2020-01-08 12:00:05 | What Makes BioDelivery BDSI a New Buy Stock

2020-01-06 08:30:10 | BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development

2019-12-30 09:44:02 | Flexion's FLXN Stock Up on FDA Approval for Zilretta sNDA

2019-12-27 19:53:00 | Argo Group, Tivity Health, Horizon Global, and Other 13D Filings

2019-12-25 12:00:05 | Are You Looking for a Top Momentum Pick? Why BioDelivery Sciences International BDSI is a Great Choice

2019-12-19 08:30:10 | BioDelivery Sciences Added to NASDAQ Biotechnology Index

2019-12-12 11:30:04 | BioDelivery BDSI Up 6% Since Last Earnings Report: Can It Continue?

2019-12-10 10:48:39 | Did Hedge Funds Drop The Ball On BioDelivery Sciences International, Inc. BDSI ?

2019-12-06 12:00:05 | What Makes BioDelivery Sciences International BDSI a Strong Momentum Stock: Buy Now?

2019-12-05 09:07:02 | Zealand Initiates Second Late-Stage CHI Study on Dasiglucagon

2019-12-04 10:06:03 | Zacks.com featured highlights include: Sciences International, Air Industries, Hallmark Financial Services and Vector

2019-12-03 09:16:02 | Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU

2019-12-03 08:57:01 | 5 Affordable Breakout Stocks for Stunning Returns

2019-11-29 09:13:02 | BioDelivery's Belbuca Sales & Symproic Addition Encouraging

2019-11-27 08:30:10 | BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference

2019-11-25 08:30:10 | BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors

2019-11-22 09:48:02 | The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical

2019-11-20 10:00:03 | What Makes BioDelivery Sciences International BDSI a Strong Momentum Stock: Buy Now?

2019-11-19 09:26:02 | Protalix Finalizes Accelerated Approval Pathway for PRX-102

2019-11-14 10:20:03 | BioDelivery BDSI Stock Up on Q3 Earnings Beat & Raised View

2019-11-13 14:48:40 | Edited Transcript of BDSI earnings conference call or presentation 12-Nov-19 9:30pm GMT

2019-11-13 08:00:01 | IVERIC bio ISEE Q3 Loss Narrows Y/Y, Zimura Advancing Well

2019-11-13 07:49:12 | 5 Breakout Stocks for Explosive Returns